![Jeno Gyuris](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeno Gyuris
Fondateur chez
Sporos Bioventures, Inc.
Profil
Jeno Gyuris is the founder of Sporos Bioventures LLC.
Current jobs include Director, Chief Scientific Officer & EVP at Asylia Therapeutics, Inc. and Partner at Cure Ventures Management LP since 2023.
Former jobs include President & Chief Scientific Officer at Stellanova Therapeutics, Inc., Vice President-Molecular Technologies at GPC Biotech, Inc. in 2002, Chief Scientific Officer & Senior Vice President at AVEO Pharmaceuticals, Inc. from 2012 to 2015, Executive Vice President & Chief Scientific Officer at Quiet Therapeutics Ltd. from 2016 to 2017, Chief Scientific Officer at Trieza Therapeutics, Inc. in 2018, and Chief Scientific Officer & Advisor at Tvardi Therapeutics, Inc. from 2018 to 2023.
Education includes a doctorate from the University of Szeged and a doctorate from Harvard Medical School.
Postes actifs de Jeno Gyuris
| Sociétés | Poste | Début |
|---|---|---|
Asylia Therapeutics, Inc.
 Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for the immune diseases | Directeur Technique/Scientifique/R&D | - |
Sporos Bioventures, Inc.
 Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Fondateur | - |
Cure Ventures Management LP
 Cure Ventures Management LP Investment ManagersFinance Cure Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life science and biotechnology sectors. It provides financing for seed and early stage capital requirements. It acts as a lead investor and also makes follow-on investments. | Private Equity Investor | 01/02/2023 |
Anciens postes connus de Jeno Gyuris
| Sociétés | Poste | Fin |
|---|---|---|
Tvardi Therapeutics, Inc.
 Tvardi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel and oral molecule therapies for STAT3 to treat fibrosis-driven diseases | Consultant / Advisor | 31/01/2023 |
Trieza Therapeutics, Inc.
 Trieza Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Corporate Officer/Principal | 31/12/2018 |
Quiet Therapeutics Ltd.
 Quiet Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops a proprietary nanoparticle-based delivery system for the targeted delivery of chemotherapy and anti-inflammatory drugs | Corporate Officer/Principal | 01/08/2017 |
| AVEO PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 15/01/2015 |
GPC Biotech, Inc.
 GPC Biotech, Inc. Drugstore ChainsRetail Trade Develops anticancer drugs | Corporate Officer/Principal | 01/01/2002 |
Formation de Jeno Gyuris
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
59
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade Develops anticancer drugs | Retail Trade |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
University of Szeged
 University of Szeged Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quiet Therapeutics Ltd.
Quiet Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops a proprietary nanoparticle-based delivery system for the targeted delivery of chemotherapy and anti-inflammatory drugs | Health Technology |
Trieza Therapeutics, Inc.
Trieza Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Health Technology |
Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel and oral molecule therapies for STAT3 to treat fibrosis-driven diseases | Health Technology |
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life science and biotechnology sectors. It provides financing for seed and early stage capital requirements. It acts as a lead investor and also makes follow-on investments. | Finance |
Asylia Therapeutics, Inc.
Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for the immune diseases | Health Technology |
Sporos Bioventures, Inc.
Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Stellanova Therapeutics, Inc.
 Stellanova Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapies targeting cancer-?associated fibroblasts and their symbiotic interactions within the tumor microenvironment | Health Technology |
